Correlation between Acylcarnitine and Peripheral Neuropathy in Type 2 Diabetes Mellitus
Table 1
Population and clinical characteristics of patients with T2DM.
Variables
DPN
Non-DPN
N
270 (53.1%)
238 (46.9%)
Age, years
0.001
Duration of diabetes, month
96.00 (24.00, 168.00)
36.00 (5.50, 120.00)
<0.001
Male, gender
138 (51.1%)
137 (57.6%)
0.145
Weight, kg
74.17(±15.53)
0.012
BMI, kg/m2
25.10 (22.90, 28.03)
25.39 (23.42, 28.09)
0.105
BMI categories
0.110
<24
104 (38.52%)
70 (29.41%)
24~ 28
97 (35.93%)
99 (41.60%)
≥28
67 (24.81%)
65 (27.31%)
Missing value
2 (0.74%)
4 (1.68%)
WC, cm
0.208
HC, cm
0.004
WHR, %
0.340
SBP, mmHg
0.615
DBP, mmHg
0.060
CP
1.40 (0.86, 2.00)
1.40 (0.87, 2.12)
0.590
HbA1c, %
0.029
HbA1c categories
0.427
219 (81.1%)
192 (80.7%)
7
33 (12.2%)
23 (9.7%)
Missing value
18 (6.7%)
23 (9.7%)
TG, mmol/L
1.97 (1.18, 3.24)
1.93 (1.23, 3.23)
0.730
TC, mmol/L
0.539
LDL-C, mmol/L
0.838
LDL-C categories
0.625
LDL-C ≥ 2.6
149 (55.2%)
118 (49.6%)
LDL-C < 2.6
67 (24.8%)
59 (24.8%)
Missing value
54 (20.0%)
61 (25.6%)
HDL-C, mmol/L
0.501
HDL-C categories
0.337
<1 in male or < 1.3 in female
129 (47.8%)
92 (38.7%)
≥1 in male or ≥ 1.3 in female
80 (29.6%)
70 (29.4%)
Missing value
61 (22.6%)
76 (31.9%)
DR
40 (14.8%)
19 (8.0%)
0.016
DN
92 (34.1%)
63 (26.6%)
0.068
DPVD
208 (77.0%)
134 (56.3%)
<0.001
Smoking
88 (32.7%)
81 (34.2%)
0.728
Drinking
81 (30.1%)
82 (34.7%)
0.266
Treatment categories
<0.001
Untreated
44 (16.3%)
82 (34.5%)
Insulin
69 (25.6%)
41 (17.2%)
Insulin and other antidiabetic medications
59 (21.9%)
36 (15.1%)
Other antihypertensive drugs
98 (36.3%)
79 (33.2%)
Data are represented as (%), , and median (interquartile range). values for comparisons between groups derived by Student’s -test. values for comparisons between groups derived by the chi-squared test. values for comparisons between groups derived by the Wilcoxon signed-rank test.
